Post‐Traumatic Stress Symptoms (PTSS) in Transplant Recipients — CTOTC-11

Solid Organ Transplant Recipients Clinical Trial

Official title:
Prevalence and Correlates of Post-Traumatic Stress Symptoms (PTSS) in Adolescent Solid Organ Transplant Recipients (CTOTC-11)

Status Completed

Clinical Trial Summary

This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine.

Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Parent(s)/Guardian of Referenced Transplant Recipients
Solid Organ Transplant Recipients

Clinical Trial Details

NCT number	NCT02892266
Study type	Observational
Source	National Institute of Allergy and Infectious Diseases (NIAID)
Contact
Status	Completed
Phase
Start date	September 2016
Completion date	November 24, 2018

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05860881` - Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)	Phase 3
Withdrawn	`NCT05234398` - TIXAGEVIMAB/CILGAVIMAB Protection of Covid-19 in Transplanted Patients
Completed	`NCT05148806` - Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies